An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich's ataxia (2022)
Attributed to:
Transplantation of genetically modified haematopoietic stem cells for Friedreich's Ataxia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-31450-w
PubMed Identifier: 35945193
Publication URI: http://europepmc.org/abstract/MED/35945193
Type: Journal Article/Review
Parent Publication: Nature Communications
Issue: 1